Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if LITS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
6 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 2
34 filers reported a long position in LITS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $1.2M | 1.2M | -28.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | $942.2K | 1M | -2.1% |
| RLH Capital LLC | $743.9K | 806.4K | New |
| TWO SIGMA INVESTMENTS, LP | $513.8K | 557K | -9.3% |
| GEODE CAPITAL MANAGEMENT, LLC | $337.1K | 365K | -9% |
| CITADEL ADVISORS LLC | $329.8K | 357.5K | -51% |
| BlackRock, Inc. | $254.4K | 275.8K | +74.7% |
| MARSHALL WACE, LLP | $214.3K | 233K | -30.1% |
| VANGUARD FIDUCIARY TRUST CO | $180.2K | 195.4K | +0.7% |
| JANE STREET GROUP, LLC | $177.7K | 192.6K | +236.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.